NAMPT-specific inhibitors reduce NAD levels by inhibiting energy metabolism pathways, such as glycolysis, TCA, and OXPHOS, contributing to the suppression of cancer cell proliferation [178,181,182]. This evidence concerns the gene NAMPT and cancer.